Back to Newsroom

PTC Therapeutics Expands Access For Translarna™ (Ataluren)

SOUTH PLAINFIELD, N.J., Nov. 3, 2014 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Translarna™ (ataluren) has been approved to be included in the list of drugs reimbursable by the Italian National Health System under Law 648/96. The decision is expected to be formalized through its publication in the official Italian journal, Gazzetta Ufficiale in the coming weeksA list of drugs reimbursable under this law is published on the Italian Medicines Agency’s (AIFA) website.

Click here to read more